Evidence map›Paper›PMID 34269900›Full record

ReviewCurrent cardiology reports2021

The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy.

Ramone Eldemire, Charles A Tharp, Matthew R G Taylor, Orfeo Sbaizero, Luisa Mestroni

Open access · greenAbstract readReview
In one paragraph

Review in Current cardiology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Novel Drug Targets in Diastolic Heart Disease.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  5. Review
  6. RNA-Binding Proteins in Cardiomyopathies.Journal of cardiovascular development and disease · 2024
    Review
  7. Genetics of Dilated Cardiomyopathy.Annual review of medicine · 2024
    Review
  8. Anthracycline Toxicity: Light at the End of the Tunnel?Annual review of pharmacology and toxicology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Novel Nonsense PathogenicCurrent issues in molecular biology · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Discerning the Ambiguous Role of MissenseJournal of personalized medicine · 2022
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ramone EldemireUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Charles A TharpUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Matthew R G TaylorUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Orfeo SbaizeroUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Luisa MestroniUniversity of Colorado Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. LUISA.MESTRONI@CUANSCHUTZ.EDU.ORCID http://orcid.org/0000-0003-1116-2286
University of Colorado Anschutz Medical Campus · USUniversity of Trieste · IT

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic CardiomyopathyR01HL116906 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MARCUS, FRANK I, MESTRONI, LUISA · 2013 to 2016
$9.2M
POSTGRADUATE TRAINING IN CARDIOVASCULAR RESEARCHT32HL007822 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BUTTRICK, PETER N., LEINWAND, LESLIE ANNE · 1996 to 2023
$6.2M
Molecular Epidemiology of Dilated CardiomyopathR01HL069071 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA · 2002 to 2005
$2.3M
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathyR01HL109209 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI TAYLOR, MATTHEW R · 2012 to 2016
$2.1M
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathyR01HL147064 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA, TAYLOR, MATTHEW R · 2020 to 2023
$2.1M
Familial Dilated Cardiomyopathy:Genetic CharacterizationK23HL067915 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI TAYLOR, MATTHEW R · 2002 to 2006
$653k
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NHGRI NIH HHS UM1 HG006542NHLBI NIH HHS K23 HL067915NHLBI NIH HHS R01 HL069071NHLBI NIH HHS R01 HL109209NHLBI NIH HHS R01 HL116906NHLBI NIH HHS R01 HL147064NHLBI NIH HHS T32 HL007822
6 · The paper itself

Abstract

purpose of reviewThe giant protein titin forms the "elastic" filament of the sarcomere, essential for the mechanical compliance of the heart muscle. Titin serves a biological spring, and therefore structural modifications of titin affect function of the myocardium and are associated with heart failure and cardiomyopathy. RECENT

findingsIn this review, we discuss the current understanding of titin's biophysical properties and how modifications contribute to cardiac function and heart failure. In addition, we review the most recent data on the clinical impact and phenotype heterogeneity of TTN truncating variants, including diseases involving striated muscles, and prospects for future therapies. Because of the giant structure of the titin protein and the complexity of its function, titin's role in health and disease is not yet completely understood. Future research efforts need to focus on novel therapeutic approaches able to modulate titin transcriptional and post-translational modification.

Indexed as

CardiomyopathiesHeart FailureConnectinHeartHumansMutationMyocardiumSarcomeresConnectinDiastolic dysfunctionDilated cardiomyopathyGenetic testingGenetic variantsHeart failureSarcomereTitin

Identifiers

PMID34269900
PMCPMC8522185
OpenAlexW3179604064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.